OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: * Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? * If effective, which facets of the peer model are most effective? Peer coaches will undergo peer coach training. * Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and goal setting. * Retain records of contact…
Conditions studied
Diabetes Mellitus, Type 2
About this study
The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: * Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? * If effective, which facets of the peer model are most effective? Peer coaches will undergo peer coach training. * Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and goal setting. * Retain records of contact, topics discussed, and general notes on interactions. Researchers will compare differences in the frequency of contact, as well as how peer coaches were matched to peer participants to see if efficacy of the intervention is altered between groups.
Interventions
- Behavioral: Peer Coaching - Peer Participants A — Peer participants in group A will be contacted by peer coaches on a weekly basis.
- Behavioral: Peer Coaching - Peer Participants B — Peer participants in group B will be contacted by peer coaches on a bi-weekly basis.
- Behavioral: Peer Coaching - Peer Participants C — Peer participants in group C will be contacted by peer coaches on a weekly basis.
- Behavioral: Peer Coaching - Peer Participants D — Peer participants in group D will be contacted by peer coaches on a bi-weekly basis.
Primary outcomes
- Number of Participants with Change in A1c (Collected at Baseline, 6 months (at the end of the intervention), 3-months and 6-months post-intervention.)
Eligibility information
Study locations
- Barren River Area Development District, Bowling Green, Kentucky 42101 United States
- UK HealthCare, Hazard, Kentucky 41701 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-03.